Articles from Genexa

Genexa, the first clean medicine brand, founded by parents to transform the medicine aisle, today released its 2025 State of the Sick Day. A national YouGov survey commissioned by Genexa, of 1,000 U.S. mothers with children under 18, uncovered a major cultural shift in how families navigate the season, riddled by missed school days, late-night supply runs, and lost sleep due to upticks in cold and flu rates.

In a category long dominated by legacy brands and artificial additives, a new national survey reveals a powerful shift: U.S. pediatricians overwhelmingly prefer the ingredient profiles in Genexa’s pediatric pain and fever liquid medicines over those in Children’s Tylenol® top-selling comparable products. Genexa is the first clean medicine company, revolutionizing the over-the-counter (OTC) medicine aisle by making medicine with the same effective active ingredients as the leading brands, but without any artificial additives.

As the impending cold and flu season draws near, Genexa proudly announces the debut of its highly acclaimed clean, and effective, line of over-the-counter (OTC) children’s medicines at Whole Foods Market stores. Genexa Kids’ Pain & Fever (acetaminophen), Kids’ Allergy (diphenhydramine), and Kids’ Tummy Relief (calcium carbonate) medicines will be available at Whole Foods Markets Stores nationwide and provide parents with OTC options that comply with Genexa’s stringent ingredient standards that ban many ingredients commonly found in other OTCs. In addition, most products are certified vegan and all are certified gluten-free.

Ahead of the 2024 cold and flu season, Genexa has today introduced new clean over-the-counter (OTC) kids’ medicine innovations, further reinforcing the company’s pioneering role in bringing clean, effective medicines to consumers. The new Kids’ Multi-Symptom Cold & Flu and Kids’ Daytime + Nighttime Cough Relief Value Pack provide parents with much-needed clean OTC options with the same effective active ingredients as legacy brands but without any dyes and artificial sweeteners, parabens, or common allergens. These products are made with the brand’s signature organic agave syrup, a unique replacement for the artificial fillers commonly found in other pediatric oral suspensions.

As parents stock up the medicine cabinet for back-to-school season, Genexa, the pioneer of the clean over-the-counter (OTC) medicine category, has today introduced its best-selling children’s product in a new organic flavor – Kids’ Pain & Fever Cherry. This latest innovation, like all of Genexa’s OTC medicines for infants, kids and adults, features the same trusted and effective active ingredients as legacy brands but without any of the dyes, artificial sweeteners, common allergens, parabens and other artificial fillers that are commonly used additives in competitor brands.

Genexa, the first and only clean over-the-counter (OTC) medicine company making medicines for the entire family, announced today that the company has been granted a patent for its drinkable agave-based medicines containing acetaminophen, applicable to its best-selling Infants’ Pain & Fever and Kids’ Pain & Fever products. Genexa makes medicine using the same effective active ingredients as category leaders such as Tylenol®, Benadryl®, Mucinex® and Robitussin®, but differentiates itself from its competitors by refusing to use any artificial inactive ingredients – no artificial sweeteners, dyes, or common allergens. Artificial fillers typically comprise more than half of what is ingested each time traditional medicines are used.

Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry about – what appears to be an emerging shortage of infants’ and kids’ pain relievers and fever reducers, which first impacted Canada and now seems to be a growing concern in the United States.

With the prediction of an early and aggressive 2022 flu season ahead, Genexa—the first clean medicine company to remove all artificial inactive ingredients from its medicines—announced today the launch of Cough & Chest Congestion for adults, a powerful maximum strength cough suppressant and expectorant designed to temporarily control cough, relieve chest congestion, and help thin and loosen mucus.

For the first time ever, adults can opt for a clean alternative with the same efficacy as its counterparts in the medicine aisles. Launched today, Genexa’s Acetaminophen Extra Strength and Acetaminophen PM caplets have the same active ingredients and dosages of current category leaders but without artificial dyes, synthetic fillers and other artificial preservatives. Genexa® Acetaminophen Extra Strength has 500mg of the pain reliever acetaminophen, the same dosage found in Extra Strength Tylenol®, and Genexa® Acetaminophen PM has 500mg of the pain reliever acetaminophen and 25 mg of diphenhydramine HCl, the same dosage found in Tylenol® PM.

Genexa, makers of the world’s first clean medicines – made with the same effective active ingredients as conventional brands but without any of the artificial fillers – has appointed Emily Culp as the company’s new Chief Marketing Officer (CMO). Culp will lead all branding, marketing and eCommerce for Genexa, bringing with her more than two decades of experience in marketing and eCommerce and a proven track record in accelerating growth by building consumer-centric brands across channels and geographies, driving business transformation, and introducing innovative new products.

Genexa has today announced that after surveying pediatricians around the country, pediatricians prefer Genexa’s Kids’ Pain & Fever over Children’s Tylenol Pain + Fever liquid products for their own children based upon comparing the ingredients. Genexa is the world’s first clean, over the counter pharmaceutical company, which makes medicine for infants, kids and adults, with the same effective active ingredients as the category leaders but without unnecessary artificial ingredients for the first time ever.

Genexa, the world’s first clean, over-the-counter pharmaceutical company, has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space. Marking a seminal development in the consumer healthcare industry, Genexa’s oversubscribed campaign was the largest Series A ever raised for an OTC medicine company, substantiating the dramatic shift of consumers looking for cleaner options. Initially seeking $25 million in capital, Genexa upsized the round because of the caliber of the investors and celebrities that wanted to be involved in spearheading the creation of a cleaner and more transparent medicine aisle.